Dan Leonard Analyst Performance

Dan Leonard is a stock analyst at UBS Group focused in the medical sector, covering 34 publicly traded companies. Over the past year, Dan Leonard has issued 21 stock ratings, including buy, hold, and sell recommendations. While full access to Dan Leonard's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Dan Leonard's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Analyst Ranking

Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat

Average Return

00.00% 12-Month ROI

Success Rate

00.00% Profitable Ratings

Total Ratings

92 Last 10 Years

Buy Recommendations

65.93% 60 Buy Ratings

Companies Covered

34 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	65.9%	60 ratings
Hold	33.0%	30 ratings
Sell	1.1%	1 ratings

Out of 91 total stock ratings issued by Dan Leonard at UBS Group, the majority (65.9%) have been Buy recommendations, followed by 33.0% Hold and 1.1% Sell.

Best & Worst Calls

• Best Call

  0000.0%

  HTGM

  Mar 2016

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.
• Worst Call

  000.0%

  CDNA

  Apr 2016

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	58.8% of companies on NASDAQ	20 companies
NYSE	41.2% of companies on NYSE	14 companies

Dan Leonard, an analyst at UBS Group, currently covers 34 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 32 companies	94.1%
	Computer and Technology 1 company	2.9%
	Miscellaneous 1 company	2.9%

Dan Leonard of UBS Group specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology and companies.

Coverage Industries

Industry	Percentage
MEDICAL SERVICES 7 companies	20.6%
MED - BIOMED/GENE 6 companies	17.6%
MED INSTRUMENTS 6 companies	17.6%
MEDICAL LABORATORIES 3 companies	8.8%
MED PRODUCTS 2 companies	5.9%
ANALYTICAL INSTRUMENTS 2 companies	5.9%
MEDICAL INFO SYS 1 company	2.9%
MED - OUTP/HM CRE 1 company	2.9%
SURGICAL & MEDICAL INSTRUMENTS 1 company	2.9%
SKILLED NURSING CARE FACILITIES 1 company	2.9%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC 1 company	2.9%
INSTRU - SCIENTFC 1 company	2.9%
Miscellaneous 1 company	2.9%
MEDICAL INSTRUMENTS & SUPPLIES 1 company	2.9%

Dan Leonard's Ratings History at UBS Group

Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe

Start Date

End Date

All Ratings Strong Buy Buy Hold Sell Rating

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription

12-Month ROIUpgrade to All Access to use the All ROI Filter

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating	12-Month Price & ROI	Details
TXG 10x Genomics	8/8/2025	Boost Price Target	$12.07	$13.00	Neutral	$0.00 00.00% ROI
EXAS Exact Sciences	8/7/2025	Lower Price Target	$41.32	$53.00	Neutral	$0.00 00.00% ROI
CERT Certara	8/7/2025	Lower Price Target	$11.31	$15.00	Buy	$0.00 00.00% ROI
MEDP Medpace	7/29/2025	Downgrade	$453.05	$305.00	Sell	$0.00 00.00% ROI
TMO Thermo Fisher Scientific	7/24/2025	Boost Price Target	$478.05	$500.00	Neutral	$0.00 00.00% ROI
DHR Danaher	7/23/2025	Lower Price Target	$198.05	$225.00	Buy	$0.00 00.00% ROI
IQV IQVIA	7/23/2025	Boost Price Target	$194.46	$225.00	Buy	$0.00 00.00% ROI
TMO Thermo Fisher Scientific	7/8/2025	Downgrade	$426.65	$460.00	Neutral	$0.00 00.00% ROI
MTD Mettler-Toledo International	5/20/2025	Upgrade	$1,159.20	$1,350.00	Buy	$0.00 00.00% ROI
TXG 10x Genomics	5/13/2025	Lower Price Target	$9.68	$12.00	Neutral	$0.00 00.00% ROI
TECH Bio-Techne	5/9/2025	Lower Price Target	$49.98	$70.00	Buy	$0.00 00.00% ROI
IQV IQVIA	5/7/2025	Lower Price Target	$149.18	$185.00	Buy	$0.00 00.00% ROI
BIO Bio-Rad Laboratories	5/2/2025	Lower Price Target	$236.83	$310.00	Buy	$0.00 00.00% ROI
RVTY Revvity	5/1/2025	Upgrade	$93.34	$115.00	Buy	$0.00 00.00% ROI
GH Guardant Health	5/1/2025	Boost Price Target	$48.50	$70.00	Buy	$0.00 00.00% ROI
TMO Thermo Fisher Scientific	4/24/2025	Lower Price Target	$421.04	$500.00	Buy	$0.00 00.00% ROI
DHR Danaher	4/23/2025	Lower Price Target	$203.97	$240.00	Buy	$0.00 00.00% ROI
IQV IQVIA	2/7/2025	Lower Price Target	$208.92	$255.00	Buy	$0.00 00.00% ROI
AVTR Avantor	1/17/2025	Reiterated Rating	$22.60	$25.00	Neutral	$0.00 00.00% ROI
CRL Charles River Laboratories International	1/17/2025	Reiterated Rating	$165.60	$185.00	Neutral	$0.00 00.00% ROI

Stock Forecasts and Research Tools

Sign in to your free account to enjoy these benefits

• In-depth profiles and analysis for 20,000 public companies.
• Real-time analyst ratings, insider transactions, earnings data, and more.
• Our daily ratings and market update email newsletter.

Sign in to your free account to enjoy all that MarketBeat has to offer.

• Sign In
• Create Account

Your Email Address:

Email Address Required

Your Password:

Password Required

Log In

---

or

Sign in with Facebook Sign in with Google

Forgot your password?

Your Email Address:

Please enter your email address.

Please enter a valid email address

Choose a Password:

Please enter your password.

Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character.

Create My Account (Free)

---

or

Sign in with Facebook Sign in with Google

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.